Press Room
Recent Press Releases
-
July 19, 2019
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis -
July 18, 2019
Gilead to Present New Data on HIV Prevention, Treatment and Cure Research at IAS 2019 -
July 17, 2019
Gilead Sciences Announces Changes to Senior Leadership Team -
July 17, 2019
Gilead Sciences’ Chief Scientific Officer John McHutchison to Leave the Company -
July 16, 2019
Gilead Sciences to Release Second Quarter 2019 Financial Results on Tuesday, July 30, 2019
Media Inquiries
For additional information about our work, please contact the Gilead public affairs team by calling 1-800-GILEAD-5
Company Statements
Find important Gilead announcements, leadership perspectives, and other corporate communications.